RxDoctor Payments Data

Dustin Doyle, DPM

Foot & Ankle Surgery · Glendale, AZNPI 1043525314

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.9%), food and beverage and education — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 22.7%. Reporting peaked in 2019 at $6,379 and has fallen 63.0% since, to $2,362 in 2025.

$17,629in general payments, 2019–2025

Across 165 payments — averaging $106.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medartis Inc.$4K
  • Treace Medical Concepts, Inc.$3K
  • Trimed, Inc.$3K
  • Arthrex$2K
  • Impactortho, Inc.$2K
  • Linvatec Corporation$796
  • plus $3K from 21 others

What the payments were for

  • Travel & lodging$9,14652%
  • Food & beverage$6,63938%
  • Education$1,84410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,629 in reported general payments places this provider in the 85th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$95,476
Medicare patients
325
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip40$1,391
Terbinafine Hcl31$679
Methylprednisolone50$413
Gabapentin67$401
Allopurinol29$230
Cephalexin20$165
Meloxicam40$121
Diclofenac Sodium27$116

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →